Skip to content
Open access

Enhancing early Alzheimer's disease clinical trials through prognostic score covariate adjustment

Sep 2026 · Alzheimer's & Dementia · Vol 22 · 0 citations · 50 references
Medicine

Abstract

A prognostic score (PS) summarizes a patient's expected disease progression and can increase the statistical efficiency of clinical trials when included as an analysis covariate.

Read PDF

Similar papers

Review Open access Sep 2026

More efficient screening for preclinical Alzheimer's clinical trials using mixture of experts

Blood plasma biomarkers identifying Alzheimer's disease (AD) neuropathology offer accessible and scalable alternatives to lumbar puncture and positron emission tomography (PET) scans, with potential efficiency gains in clinical trial recruitment.

O. Langford, R. Raman, P. Aisen et al. · 1 citation
Open access Sep 2026

Transcriptional risk score for chronic kidney disease: relation to Alzheimer's disease

The impact of CKD transcriptional risk on AD endophenotypes is assessed by assessing the impact of CKD transcriptional risk on AD endophenotypes in individuals with chronic kidney disease.

Jung-Min Pyun, Young Ho Park, Jiyun Hwang et al. · 0 citations
Open access Sep 2026

Protein Biomarkers in Risk and Prognosis of Amyotrophic Lateral Sclerosis

Plasma and cerebrospinal fluid (CSF) protein biomarkers in amyotrophic lateral sclerosis (ALS) may provide insight into disease mechanisms and yield clinically useful biomarkers.

Lu Pan, C. Hou, Christina Seitz et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.